Humoral immune response to COVID‐19 vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: the prospective …

…, M Stradner, P Schlenke, N Sareban… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aims To investigate the seroconversion following first and second COVID‐19 vaccination in
people with type 1 and type 2 diabetes in relation to glycaemic control prior to vaccination …

SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia

…, P Eller, P Wilhelmer, F Eisner, N Sareban… - Journal of …, 2021 - journalofinfection.com
The model is a discretized version of a Susceptible Infectious and Recovered (SIR)-type
model 7 We have set R0= 1. 17 based on current data in our area. 8 We estimated the initial …

[HTML][HTML] CD19+ IgD+ CD27-naive B cells as predictors of humoral response to COVID 19 mRNA vaccination in immunocompromised patients

…, I Hodl, P Forstner, S Hatzl, N Sareban… - Frontiers in …, 2021 - frontiersin.org
Immunocompromised patients are considered high-risk and prioritized for vaccination
against COVID-19. We aimed to analyze B-cell subsets in these patients to identify potential …

[HTML][HTML] Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage

…, C Borsodi, L Weidner, N Sareban… - Clinical Chemistry and …, 2023 - degruyter.com
Objectives The WHO’s standardized measuring unit, “binding antibody units per milliliter (BAU/mL),”
should allow the harmonization of quantitative results by different commercial Anti-…

[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third …

…, B Kleinhappl, M Stradner, N Sareban… - Diabetes, Obesity & …, 2023 - ncbi.nlm.nih.gov
2. METHODS The ‘Immune response to COVID‐19 vaccination in people with Diabetes
Mellitus—COVAC‐DM’study prospectively investigated the impact of diabetes and glycaemic …

[HTML][HTML] Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study

S Kral, C Banfi, T Niedrist, N Sareban… - Journal of …, 2021 - journalofinfection.com
Wells et al. investigated seroprevalence of SARS-CoV-2 antibodies in a cohort of 431 non-hospitalized
UK twins (mean age= 48.38, SD= 28; 85.1% female), who systematically …

[HTML][HTML] High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled …

S Macher, C Drexler, I Lindenau, N Sareban… - Trials, 2016 - Springer
Background About 2–3 % of the population participates in blood donation programmes. Each
whole blood donation or ten apheresis donations cause a loss of 200–250 mg of iron. As a …

Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy

I Hodl, C Sallegger, P Forstner, N Sareban… - Microbes and …, 2023 - Elsevier
B-cell depleting therapies result in diminished humoral immunity following vaccination against
COVID-19, but our understanding on the impact on cellular immune responses is limited. …

Platelet antibody analysis by three different tests

N Sareban, S Macher, C Drexler… - Journal of Clinical …, 2015 - Wiley Online Library
Background Platelet‐reactive antibodies lead to thrombocytopenia and bleeding disorders,
and diverse assays are used for their detection. In this retrospective analysis, the …

[HTML][HTML] Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study

S Hatzl, F Posch, N Sareban, M Stradner… - Annals of Intensive …, 2021 - Springer
Background This study aimed to quantify the potential survival benefit of convalescent plasma
therapy (CVP) in critically ill patients with acute respiratory failure related to coronavirus …